Migraine prevalence in male to female transsexuals on hormone therapy
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Migraine prevalence is three times higher in women than men, suggesting that sex hormones may be involved in migraine generation. To further understand the relationship between migraine and sex hormones, we assessed male to female transsexuals (MFTs) using antiandrogens to suppress male sex characteristics and estrogens to induce female sex characteristics for the presence of headache.
Methods.
The Gender Team Clinic has treated >900 MFTs and provides comprehensive care for 95% of transsexuals in The Netherlands. A questionnaire consisting of eight multiple choice questions on headache frequency, duration, intensity, pain location, associated symptoms, and visual phenomena was distributed during a 4-month period to MFTs who had recently completed sex reassignment surgery. Headaches before taking hormone therapy were not assessed because of the long period (years) many patients had taken treatment. Migraine diagnosis was based on satisfaction of International Headache Society (IHS) criteria.
We calculated the expected number of persons with migraine based on …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jessica Ailani and Dr. Ailna Masters-Israilov
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Pediatric migraine and the International Headache Society (IHS) criteriaJoseph Maytal, Melissa Young, Aaron Shechter et al.Neurology, March 01, 1997 -
Articles
Migraine, headache, and the risk of stroke in womenA prospective studyT. Kurth, M. A. Slomke, C. S. Kase et al.Neurology, March 21, 2005 -
Articles
Estrogen replacement therapy and longitudinal decline in visual memoryA possible protective effect?Susan M. Resnick, E. Jeffrey Metter, Alan B. Zonderman et al.Neurology, December 01, 1997 -
Articles
ACE D/I polymorphism, migraine, and cardiovascular disease in womenM. Schürks, R.Y.L. Zee, J. E. Buring et al.Neurology, February 16, 2009